HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Nakajima Selected Research

Biomarkers (Surrogate Marker)

1/2015Monitoring gastric cancer progression with circulating tumour DNA.
4/2001Esophageal hypomotility in systemic sclerosis: close relationship with pulmonary involvement.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Nakajima Research Topics

Disease

23Neoplasms (Cancer)
07/2018 - 01/2000
6Hepatocellular Carcinoma (Hepatoma)
05/2014 - 01/2000
5Type 2 Diabetes Mellitus (MODY)
03/2015 - 01/2000
5Stomach Neoplasms (Stomach Cancer)
01/2015 - 05/2000
5Human Influenza (Influenza)
06/2004 - 08/2000
4Hyperlipidemias (Hyperlipidemia)
02/2004 - 01/2000
4Atherosclerosis
12/2001 - 01/2000
3Esophageal Neoplasms (Esophageal Cancer)
07/2018 - 11/2017
3Esophageal Squamous Cell Carcinoma
11/2017 - 02/2011
3Kidney Neoplasms (Kidney Cancer)
05/2013 - 02/2001
3Renal Cell Carcinoma (Grawitz Tumor)
05/2013 - 02/2001
3Prostatic Neoplasms (Prostate Cancer)
09/2012 - 02/2000
3Infections
05/2010 - 06/2000
3Dementia (Dementias)
12/2008 - 03/2001
3Parkinson Disease (Parkinson's Disease)
12/2008 - 03/2000
3Alzheimer Disease (Alzheimer's Disease)
06/2006 - 01/2000
3Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
06/2005 - 01/2000
3Coronary Artery Disease (Coronary Atherosclerosis)
05/2004 - 06/2001
3Cardiovascular Diseases (Cardiovascular Disease)
12/2003 - 01/2001
3Hypertriglyceridemia
07/2001 - 01/2000
3Colorectal Neoplasms (Colorectal Cancer)
02/2001 - 06/2000
2Neoplasm Metastasis (Metastasis)
04/2018 - 08/2001
2Meningioma (Meningiomas)
12/2015 - 11/2002
2Insulin Resistance
12/2014 - 07/2000
2Psoriasis (Pustulosis Palmaris et Plantaris)
01/2013 - 06/2004
2Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
09/2012 - 02/2000
2Fever (Fevers)
11/2007 - 09/2001
2Rheumatoid Arthritis
09/2007 - 07/2005
2Wounds and Injuries (Trauma)
07/2006 - 01/2000
2Parkinsonian Disorders (Parkinsonism)
06/2006 - 05/2000
2Urinary Bladder Neoplasms (Bladder Cancer)
02/2006 - 05/2000
2Thrombosis (Thrombus)
12/2003 - 11/2000
2Arteriosclerosis
02/2003 - 04/2001
2Persistent Vegetative State (Vegetative State)
01/2003 - 11/2002
2Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
01/2003 - 11/2002
2Cognitive Dysfunction
01/2003 - 11/2002
2Gastroesophageal Reflux (GERD)
05/2002 - 11/2000
2Myocardial Infarction
11/2001 - 10/2001
2Carcinogenesis
11/2001 - 03/2000
2Neurodegenerative Diseases (Neurodegenerative Disease)
09/2000 - 05/2000
1Heart Failure
01/2021
1Hyperostosis
04/2020
1Carcinoma (Carcinomatosis)
11/2019
1Esophageal Perforation
04/2018
1Leukemia
01/2018
1Graft vs Host Disease (Graft-Versus-Host Disease)
01/2018

Drug/Important Bio-Agent (IBA)

9Pharmaceutical PreparationsIBA
09/2014 - 01/2000
9Proteins (Proteins, Gene)FDA Link
03/2014 - 05/2000
8Lipoproteins (Lipoprotein)IBA
05/2004 - 01/2000
6CholesterolIBA
07/2009 - 06/2000
5Triglycerides (Triacylglycerol)IBA
07/2001 - 01/2000
4AntibodiesIBA
03/2013 - 06/2000
4CytokinesIBA
01/2013 - 03/2000
4Messenger RNA (mRNA)IBA
07/2006 - 02/2000
3DNA (Deoxyribonucleic Acid)IBA
01/2015 - 02/2000
3Insulin (Novolin)FDA Link
12/2014 - 10/2001
3AutoantibodiesIBA
09/2014 - 09/2000
3EnzymesIBA
03/2013 - 06/2000
3Interleukin-6 (Interleukin 6)IBA
01/2013 - 02/2001
33-Iodobenzylguanidine (Iobenguane)IBA
12/2008 - 01/2000
3Acetazolamide (Diamox)FDA LinkGeneric
01/2003 - 11/2002
3Prednisolone (Predate)FDA LinkGeneric
09/2001 - 06/2000
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2001 - 03/2000
3LipidsIBA
01/2001 - 01/2000
2C-Reactive ProteinIBA
11/2017 - 07/2005
2Biomarkers (Surrogate Marker)IBA
01/2015 - 04/2001
2Glucose (Dextrose)FDA LinkGeneric
12/2014 - 07/2000
2Sorafenib (BAY 43-9006)FDA Link
05/2014 - 07/2012
2ImmunosorbentsIBA
03/2013 - 06/2000
2Carcinoembryonic AntigenIBA
03/2013 - 02/2001
2oxidized low density lipoproteinIBA
09/2010 - 01/2001
2AcidsIBA
07/2007 - 01/2000
2AntigensIBA
04/2007 - 02/2001
2Mitochondrial DNA (mtDNA)IBA
06/2005 - 10/2001
2Adenosine Triphosphate (ATP)IBA
03/2004 - 10/2001
2Gemfibrozil (Lopid)FDA LinkGeneric
02/2004 - 07/2001
2Cadherins (E-Cadherin)IBA
09/2001 - 08/2001
2DecitabineFDA Link
09/2001 - 08/2001
2hydrogen sulfite (bisulfite)IBA
08/2001 - 02/2000
2RNA (Ribonucleic Acid)IBA
08/2001 - 06/2000
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2001 - 04/2001
2CarbohydratesIBA
02/2001 - 01/2000
2Hemagglutinins (Hemagglutinin)IBA
12/2000 - 08/2000
2ZincIBA
09/2000 - 01/2000
2Interferon-alpha (Interferon Alfa)IBA
06/2000 - 01/2000
2iodofiltic acidIBA
01/2000 - 01/2000
1MineralsIBA
04/2020
1Phenobarbital (Luminal)FDA Link
11/2019
1Cisplatin (Platino)FDA LinkGeneric
04/2018
1Docetaxel (Taxotere)FDA Link
04/2018
1Fluorouracil (Carac)FDA LinkGeneric
04/2018
1HLA-DPB1 antigen (HLA DPB1)IBA
01/2018

Therapy/Procedure

11Therapeutics
01/2021 - 01/2000
8Drug Therapy (Chemotherapy)
04/2018 - 01/2000
4Fundoplication
05/2002 - 08/2000
2Esophagectomy
07/2018 - 11/2017
2Radiotherapy
04/2018 - 07/2000
2Lymph Node Excision (Lymph Node Dissection)
11/2017 - 05/2015
1Cardiac Resynchronization Therapy
01/2021
1Induction Chemotherapy
04/2018